Skip to main content
. 2022 May 17;11(10):1664. doi: 10.3390/cells11101664

Figure 6.

Figure 6

Expression of the anti-DARPP32 antibody in the striatum (AD) and cortex (EH) in 3-NP + Placebo (A,E), 3-NP + hIDPSC (B,C,F,G) and in control (D,H) animals, respectively. Black arrows indicate anti-DARPP32 expressing cells. (C,G) demonstrate high magnification of (B,F). Sections are contra stained with HE. Scale bars: 50 µm (A,B,E,F), 25 µm (C,G) 10 µm (D,H). Analysis performed 30 days after the treatments (D35). Asterisk indicates the enlarged areas.